Tang Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Tang Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,191,417	Closed	-$22M	–	141
2023 Q4	$22M	Buy	2,191,417 +2,032,330	+1,277%	+$9.22M	2.03%	13
2023 Q3	$458K	Buy	+159,087	New	+$582K	0.06%	96

Tang Capital Management's GRCL Position: Q1 2024 in Review

Tang Capital Management sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 2,191,417 shares — an estimated $22M sold.

Tang Capital Management first reported a position in GRCL in Q3 2023 and held it in 2 quarters. The position peaked at $22M in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Tang Capital Management reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Tang Capital Management sold 2,191,417 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $22M.
Tang Capital Management first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q3 2023 and held it in 2 quarters.
Tang Capital Management's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $22M in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Tang Capital Management's 13F filing for Q1 2024, filed 15 May 2024.